Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phlogenzym® in Patients With Acute Thrombophlebitis - Efficacy and Tolerance - Randomised Double-blind Study Phase III With Parallel Groups vs. Placebo According to the Guidelines of Good Clinical Practice (GCP)

NCT03470337 is registered in ClinicalTrials.gov with Mucos Pharma GmbH & Co. KG as lead sponsor.

NCT NCT03470337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03470337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phlogenzym® in Patients With Acute Thrombophlebitis - Efficacy and Tolerance - Randomised Double-blind Study Phase III With Parallel Groups vs. Placebo According to the Guidelines of Good Clinical Practice (GCP)
Lead sponsor
Mucos Pharma GmbH & Co. KG
Phase
Phase 3
Overall status
Completed
Start date
September 30, 1996
Completion date
June 30, 1997
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thrombophlebitis leg